Pluristem Therapeutics INITIATED at Buy and 3 Analyst-Initiated Shares to Note
July 25, 2012
Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on July 25th.
Fed Investors (NYSE:FII): RBC Capital Mkts initiated coverage of this company with a rating of Underperform and a price target of $19.
Don’t Miss: Ford Earnings: Profit Falls, Yet Revenue TOPS Analyst Estimate.
Eaton Vance (NYSE:EV): RBC Capital Mkts initiated coverage of this company with a rating of Sector Perform and a price target of $28.
BlackRock (NYSE:BLK): RBC Capital Mkts initiated coverage of this company with a rating of Outperform and a price target of $221.
Pluristem Therapeutics (NASDAQ:PSTI): Maxim Group initiated coverage of this company with a rating of Buy and a price target of $8.
Don’t Miss: Is Apple Getting Bitten in China?
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
Premium Newsletters
Gold & Silver
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
Commodities Premium
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
ETF Investing
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more
Wall St. Cheat Sheet has been featured in these fine media outlets:
